Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
IVVD
IVVD
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
IVVD News
Invivyd Grants Stock Options to New Employees
17h ago
Newsfilter
Invivyd's Q1 Revenue Misses Expectations, Shares Plummet
May 14 2026
stocktwits
Invivyd Q1 2026 Earnings Call Highlights
May 14 2026
seekingalpha
Invivyd Reports Q1 2026 Financial Results with Revenue Growth
May 14 2026
seekingalpha
Invivyd to Announce Q1 Earnings on May 14
May 13 2026
seekingalpha
Invivyd's Antibody Study Shows Low Side Effects
May 11 2026
Newsfilter
Invivyd Chairman to Speak at Health Summit
Apr 20 2026
Newsfilter
Invivyd Reports Progress in Late-Stage Trial for COVID-19 Therapy VYD2311
Apr 09 2026
seekingalpha
Invivyd Announces Progress in COVID-19 Study and New Measles Antibody Candidate
Apr 09 2026
Newsfilter
Invivyd Launches National Antibody Education Campaign
Apr 07 2026
Newsfilter
Invivyd Grants Stock Options to New Employees
Apr 06 2026
Newsfilter
BETA Technologies Reports Disappointing Q4 Results
Mar 09 2026
Benzinga
Invivyd Q4 2025 Earnings Call Highlights
Mar 05 2026
seekingalpha
Invivyd Reports Q4 2025 Financial Results and Clinical Trial Updates
Mar 05 2026
Newsfilter
Invivyd Set to Announce FY Earnings with Significant Growth Expectations
Mar 04 2026
seekingalpha
Invivyd Aligns with FDA on LIBERTY Phase 3 Trial for VYD2311
Feb 03 2026
seekingalpha
Show More News